Appropriateness of empiric antimicrobial therapy with imipenem/colistin in severe septic patients: observational cohort study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-0711
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Appropriateness of empiric antimicrobial therapy with imipenem/colistin in severe septic patients: observational cohort study ; volume:17 ; number:1 ; day:16 ; month:11 ; year:2018 ; pages:1-11 ; date:12.2018
Annals of clinical microbiology and antimicrobials ; 17, Heft 1 (16.11.2018), 1-11, 12.2018
- Urheber
-
Trifi, Ahlem
Abdellatif, Sami
Abdennebi, Cyrine
Daly, Foued
Nasri, Rochdi
Touil, Yosr
Ben Lakhal, Salah
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12941-018-0292-7
- URN
-
urn:nbn:de:101:1-2019010102344534124884
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Trifi, Ahlem
- Abdellatif, Sami
- Abdennebi, Cyrine
- Daly, Foued
- Nasri, Rochdi
- Touil, Yosr
- Ben Lakhal, Salah
- SpringerLink (Online service)
Ähnliche Objekte (12)
High adsorption capacity of hemoperfusion on imipenem in critically ill patients with septic shock: a case report
Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms
In vitro activities of colistin, imipenem and ceftazidime against drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii isolates in the south of Iran
Upstream region of OprD mutations in imipenem-resistant and imipenem-sensitive Pseudomonas isolates
Correction to: Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms
Ursolic acid inhibits colistin efflux and curtails colistin resistant Enterobacteriaceae
Pharmakokinetik von Ceftriaxon und Imipenem/Cilastatin
Activity of imipenem/relebactam and comparators against KPC-producing Klebsiella pneumoniae and imipenem-resistant Pseudomonas aeruginosa
Comparison of a Fully Empiric and a Semi-Empiric Noise Modeling Approach for a Cargo-UAV
Pharmakokinetische Untersuchungen zu Imipenem bei chirurgischen Patienten
Kurzzeitprophylaxe mit Imipenem/Cilastatin nach Sectio caesarea
Transcriptome profiling in imipenem-selected Acinetobacter baumannii
High adsorption capacity of hemoperfusion on imipenem in critically ill patients with septic shock: a case report
Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms
In vitro activities of colistin, imipenem and ceftazidime against drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii isolates in the south of Iran
Upstream region of OprD mutations in imipenem-resistant and imipenem-sensitive Pseudomonas isolates
Correction to: Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms
Ursolic acid inhibits colistin efflux and curtails colistin resistant Enterobacteriaceae
Pharmakokinetik von Ceftriaxon und Imipenem/Cilastatin
Activity of imipenem/relebactam and comparators against KPC-producing Klebsiella pneumoniae and imipenem-resistant Pseudomonas aeruginosa
Comparison of a Fully Empiric and a Semi-Empiric Noise Modeling Approach for a Cargo-UAV
Pharmakokinetische Untersuchungen zu Imipenem bei chirurgischen Patienten
Kurzzeitprophylaxe mit Imipenem/Cilastatin nach Sectio caesarea
Transcriptome profiling in imipenem-selected Acinetobacter baumannii
High adsorption capacity of hemoperfusion on imipenem in critically ill patients with septic shock: a case report
Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms
In vitro activities of colistin, imipenem and ceftazidime against drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii isolates in the south of Iran
Upstream region of OprD mutations in imipenem-resistant and imipenem-sensitive Pseudomonas isolates
Correction to: Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms
Ursolic acid inhibits colistin efflux and curtails colistin resistant Enterobacteriaceae
Pharmakokinetik von Ceftriaxon und Imipenem/Cilastatin
Activity of imipenem/relebactam and comparators against KPC-producing Klebsiella pneumoniae and imipenem-resistant Pseudomonas aeruginosa
Comparison of a Fully Empiric and a Semi-Empiric Noise Modeling Approach for a Cargo-UAV
Pharmakokinetische Untersuchungen zu Imipenem bei chirurgischen Patienten
Kurzzeitprophylaxe mit Imipenem/Cilastatin nach Sectio caesarea